We are Sorry, This Page doesn't Exist

Supernus Pharmaceuticals Inc. shares jumped more than 20% in after-hours trading Tuesday after the company revealed positive .....»»

Markets Insid.....»»

Teva's (TEVA) shares rally as it enters into an agreement to settle all patent litigation related to its abbreviated new drug application for Neos Therapeutics' ADHD drug, Cot.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. read more.....»»

Gilead Sciences, Inc. (NASDAQ: GILD) is facing another setback, as its non-alcoholic steatohepatitis, or NASH, candidate Selonsertib flunked in a late-stage study. read more.....»»

Shares of Myovant Sciences Ltd. were down 5.7% in premarket trading on Wednesday after the company told investors that the Food and Drug Administration had placed a partial clinical hold on a study assessing an experimental birth c.....»»

Shares of Reviva Pharmaceuticals Holdings Inc. soared 76.6% in trading on Monday after the company said its experimental treatment .....»»

ShaShares of Eli Lilly & Co. were down 5.2% in premarket trading on Monday, two days after the drug maker said additional clinical-trial data reinforced the role its experi.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 2) read more.....»»

Shares of Gilead Sciences Inc. were down 0.1% in premarket trading on Thursday, the day after the company said an experimental idiopathic pulmonary fibrosis drug it was developing with Galapagos failed a Phase 3 clinical trial. Shares o.....»»

U.S. stock.....»»

U.S. stock benchmarks added to strong gains Wednesday afternoon after Dr. Anthony Fauci described data from a drug trial of Gilead Sciences' remdesivir showed "quite good news," in treating certain patients stricken with the illness from th.....»»

U.S. stock index futures jumped on Wednesday after Gilead Sciences said its experimental antiviral drug met the main goal of a trial testing it in COVID-19 patients......»»

Gilead Sciences Inc. said Wednesday morning that a government-run clinical trial evaluating its experimental drug remdesivir in certain COVID-19 patie.....»»

BioSig Technology (NASDAQ: BSGM) shares are trading higher on Friday after the company's subsidiary VirtalClear submitted an investigational new drug application to the FDA for a Phase 2 clinical trial of Merimepodib. read more.....»»

Associated Press Gilead stock plunged as much as 9% on Thursday after STAT News reported its experimental coronavirus drug remdesivir failed to improve.....»»

Shares of Gilead Sciences Inc. were down 5.3% in trading on Thursday after a Stat News report said a draft of the clinical trial results for remdesivir, an experimental drug being tested as a treatment for COVID-19, showed that the drug did not spe.....»»

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Stocks spiked amid hopes the U.S. economy could reopen and promising early results for a remdesivir drug trial......»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»